H. LUNDBECK A/S
Global pharmaceutical company dedicated to advancing treatments for brain diseases.
Yleiskatsaus
- 2,119
- Työntekijät
- Tuntematon
- Liikevaihto
- 1950
- Perustettu
Avainpäättäjät
Anders Crillesen
Head of Media Relations
Christian Raadmand Jensen
Senior Director, Investor Relations
Klaus Simonsen
Vice President, Head of External Research & Innovation
Karin Hamberg
Chief Medical Officer
+25 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Lundbeck is a global pharmaceutical company headquartered in Denmark, specializing exclusively in the research, development, and commercialization of treatments for brain diseases. With over 70 years of expertise in neuroscience, the company focuses on conditions such as depression, schizophrenia, P...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Tuntematon
- Oikeudellinen muoto
- A/S
- ALV-numero
- DK56759913
Päättäjät
29 yhteystietoa FunnelfeedrissäAnders Crillesen
Head of Media Relations
Christian Raadmand Jensen
Senior Director, Investor Relations
Klaus Simonsen
Vice President, Head of External Research & Innovation
Karin Hamberg
Chief Medical Officer
Joerg Hornstein
CFO and Executive Vice President, Corporate Functions
Thomas Gibbs
Executive Vice President, Head of Lundbeck U.S.
Lars Green
Member of the Board
Tarek Samad
Senior Vice President & Global Head of Research, Corporate Patents & Trademarks
Dorothea Wenzel
Chair of the Board
Jeffrey Berkowitz
Member of the Board
Michala Fischer-Hansen
Executive Vice President, Head of Europe and International Markets
Maria Alfaiate
Executive Vice President, Corporate, Portfolio and Product Strategy
Lene Skole-Sørensen
Deputy Chair of the Board
Rita Balice-Gordon
Member of the Board
Dianne Hol
Executive Vice President, People and Culture
Bettina Laursen
Head of Operations, Lundbeck Biotech Incubator
Jakob Riis
Member of the Board
Lars Bang
Executive Vice President, Product Development and Supply
Jesper Frank Bastlund
Head of Strategy, Lundbeck Biotech Incubator
Santiago Arroyo
Member of the Board
Johan Luthman
Executive Vice President, R&D
Agathe Le Lay
Head of Global Value Evidence and Patient Insights
Lars Erik Holmqvist
Member of the Board
Camilla Gram Andersson
Employee Representative, Senior Director, Corporate Health, Safety & Environment
Charl van Zyl
President and CEO
Tine Østergaard Hansen
Senior Vice President, Corporate Communications and Public Affairs
Muut yhteyshenkilöt
Hossein Armandi
Employee Representative, Research Technician
Lasse Skibsbye
Employee Representative, Principal Scientist
Kjartan Frisch Herrik
Employee Representative, Research Fellow
Samankaltaiset yritykset
20 samankaltaista yritystä Funnelfeedrissä
LUNDBECKFOND INVEST A/S
22 työntekijätA Danish commercial foundation investing in healthcare and brain research.
ALK-ABELLÓ NORDIC A/S
14 työntekijätGlobal pharmaceutical company pioneering innovative treatments for chronic allergy conditions.
TEVA DENMARK A/S
37 työntekijätGlobal pharmaceutical leader providing affordable generic and innovative medical solutions.
BRISTOL-MYERS SQUIBB DENMARK. FILIAL AF BRISTOL-MYERS SQUIBB AB.SVERIGE
24 työntekijätGlobal biopharmaceutical company developing innovative medicines for serious diseases.
ASTRAZENECA PLC
1–4 työntekijätGlobal science-led pharmaceutical business developing life-changing medicines.
Selaa lisää
Kysymyksiä yrityksestä H. LUNDBECK A/S
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo